Search results
Found 17 matches for
NIHR Health Technology Aassessment is funding a new study looking at the risks and benefits of first line osteoporosis medications (oral bisphosphonates) amongst patients suffering from chronic kidney disease, led by Associate Professor Daniel Prieto-Alhambra of NDORMS.
WHITE-5
Botnar Hip
FAIT
Botnar Hip
FAIT is a multicentre randomised controlled clinical trial comparing surgical and non-surgical approaches to treating femoroacetabular impingement (hip impingement).
Glyn-Jones Group | Hip Research Group
Botnar Hip
Our research focuses on hip osteoarthritis, from identifying its causes to developing new surgery techniques for the condition.